Pulike Biological Engineering, Inc. (SHA:603566)
13.84
+0.49 (3.67%)
Mar 6, 2026, 3:00 PM CST
SHA:603566 Revenue
Pulike Biological Engineering had revenue of 263.58M CNY in the quarter ending September 30, 2025, a decrease of -5.39%. This brings the company's revenue in the last twelve months to 1.10B, up 1.65% year-over-year. In the year 2024, Pulike Biological Engineering had annual revenue of 1.04B, down -16.77%.
Revenue (ttm)
1.10B
Revenue Growth
+1.65%
P/S Ratio
4.29
Revenue / Employee
711.69K
Employees
1,551
Market Cap
4.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.04B | -210.13M | -16.77% |
| Dec 31, 2023 | 1.25B | 22.62M | 1.84% |
| Dec 31, 2022 | 1.23B | 131.50M | 11.97% |
| Dec 31, 2021 | 1.10B | 170.06M | 18.31% |
| Dec 31, 2020 | 928.51M | 265.32M | 40.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.67B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Assure Tech (Hangzhou) | 453.58M |
| Hangzhou Biotest Biotech | 448.37M |
| Innovita Biological Technology | 422.03M |